Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Sundry Debtors

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Sundry Debtors History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Sundry Debtors ₹848 Cr₹576 Cr₹388 Cr₹331 Cr₹531 Cr

What is the latest Sundry Debtors ratio of MANKIND PHARMA ?

The latest Sundry Debtors ratio of MANKIND PHARMA is ₹848 Cr based on Mar2024 Consolidated results.
Year Sundry Debtors
Mar2024₹848 Cr
Mar2023₹576 Cr
Mar2022₹388 Cr
Mar2021₹331 Cr
Mar2020₹531 Cr

How is Sundry Debtors of MANKIND PHARMA Trending?

Years Sundry Debtors % Change
Mar2024 ₹848 Cr
47.16
Mar2023 ₹576 Cr
48.50
Mar2022 ₹388 Cr
17.41
Mar2021 ₹331 Cr
-37.75
Mar2020 ₹531 Cr -

Compare Sundry Debtors of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹102,240.6 Cr -2.1% -0.6% 33.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,352.0 Cr 1.7% -4.7% 48.8% Stock Analytics
DIVIS LABORATORIES ₹159,265.0 Cr 4.4% 3.1% 66% Stock Analytics
CIPLA ₹120,035.0 Cr -0.9% -1.7% 17.3% Stock Analytics
DR REDDYS LABORATORIES ₹101,286.0 Cr -1% -8.9% 6.5% Stock Analytics
ZYDUS LIFESCIENCES ₹95,461.4 Cr -1% -4% 48.4% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-2.1%

-0.6%

33.1%

SENSEX

1.8%

-2.5%

19.9%


You may also like the below Video Courses